39 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
guides, communication plans for healthcare professionals, and elements to assure safe use (“ETASU”). ETASU can include, but is not limited to, specific … on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use any product candidates we may develop unless
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
8 Jan 24
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
8:00am
AML expected H1 2024 --
-- Caribou to present at 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, at 11:15 am PST --
BERKELEY … .
Caribou to present at the 42nd Annual J.P. Morgan Healthcare Conference
Dr. Haurwitz is scheduled to present a corporate update at the 42nd Annual J.P
ARS
wx8lfiu
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-99.1
2g5ptesacv3ocq7
8 Nov 22
Caribou Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm
DEF 14A
d7v7n98ishipz4d
11 Aug 22
Definitive proxy
4:04pm
S-3
nra 2tiev2c
9 Aug 22
Shelf registration
12:00am
8-K
EX-99.1
41uihy qzaj8
9 Aug 22
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
10-K
k1bvopq8sixl
21 Mar 22
Annual report
4:19pm
8-K
EX-99.1
urs5 dgep4t7wv
9 Nov 21
Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results
4:12pm
8-K
EX-99.1
kq3w456gm 7p8eq
8 Nov 21
Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer
9:10am